Insulin resistance is an important risk factor for cognitive impairment in elderly patients with primary hypertension

Yonsei Medical Journal

Volumn 56, Issue 1, 2015, Pages 89-94

  Ma, Lina ^a   Feng, Ming ^a   Qian, Yuying ^a   Yang, Wei ^a   Liu, Jia ^a   Han, Rui ^a   Zhu, Hong ^a   Li, Yun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cognitive impairment; Elderly; Hypertension; Insulin resistance; Risk factor

Indexed keywords

GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; BODY MASS; CHINESE; COGNITIVE DEFECT; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE INDEX; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; RISK FACTOR; WAIST HIP RATIO; CASE CONTROL STUDY; COGNITION DISORDERS; COMPLICATION; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; RISK FACTORS;

EID: 84918775866     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2015.56.1.89     Document Type: Article

References (36)

1. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease--is this type 3 diabetes? J Alzheimers Dis 2005;7:63-80.
2. Cukierman-Yaffee T. The relationship between dysglycemia and cognitive dysfunction. Curr Opin Investig Drugs 2009;10:70-4.
3. Craft S. Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res 2007;4:147-52.
4. Ohara T, Doi Y, Ninomiya T, Hirakawa Y, Hata J, Iwaki T, et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 2011;77:1126-34.
5. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, Breteler MM. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology 2010;75:1982-7.
6. Janson J, Laedtke T, Parisi JE, O’Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004;53:474-81.
7. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 2011;68:51-7.
8. Mielke JG, Taghibiglou C, Liu L, Zhang Y, Jia Z, Adeli K, et al. A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem 2005;93:1568-78.
9. Pratchayasakul W, Kerdphoo S, Petsophonsakul P, Pongchaidecha A, Chattipakorn N, Chattipakorn SC. Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sci 2011;88:619-27.
10. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology 2010;75:764-70.
11. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer’s disease. Neurobiol Aging 2011;32: 1942-8.
12. De Boer MP, Meijer RI, Wijnstok NJ, Jonk AM, Houben AJ, Stehouwer CD, et al. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 2012;19:5-18.
13. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26:831-43.
14. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 2007;4:13-9.
15. Haenni A, Lind L, Reneland R, Lithell H. Blood pressure changes in relation to sodium and calcium status in induced hyperinsulinemia. Blood Press 2000;9:116-20.
16. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129-46.
17. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003;46:1604-10.
18. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-6.
19. Desideri G, Kwik-Uribe C, Grassi D, Necozione S, Ghiadoni L, Mastroiacovo D, et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension 2012;60:794-801.
20. Mortamais M, Portet F, Brickman AM, Provenzano FA, Muraskin J, Akbaraly TN, et al. Education modulates the impact of white matter lesions on the risk of mild cognitive impairment and dementia. Am J Geriatr Psychiatry 2014;22:1336-45.
21. Kavanagh K, Fairbanks LA, Bailey JN, Jorgensen MJ, Wilson M, Zhang L, et al. Characterization and heritability of obesity and associated risk factors in vervet monkeys. Obesity (Silver Spring) 2007;15:1666-74.
22. Gustafsson S, Lind L, Söderberg S, Zilmer M, Hulthe J, Ingelsson E. Oxidative stress and inflammatory markers in relation to circulating levels of adiponectin. Obesity (Silver Spring) 2013;21: 1467-73.
23. Luchsinger JA. Adiposity, hyperinsulinemia, diabetes and Alzheimer’s disease: an epidemiological perspective. Eur J Pharmacol 2008;585:119-29.
24. Salkovic-Petrisic M, Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 2007:217-33.
25. Apparsundaram S, Sung U, Price RD, Blakely RD. Trafficking-dependent and-independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J Pharmacol Exp Ther 2001;299:666-77.
26. Liu H, Xu J, Qu L. Recent study on the relationship between insulin resistance and stroke. Chin J Clin Rehabil 2003;7:3864-6.
27. Jagust W, Harvey D, Mungas D, Haan M. Central obesity and the aging brain. Arch Neurol 2005;62:1545-8.
28. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007;21:167-71.
29. Zhao WQ, Townsend M. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer’s disease. Biochim Biophys Acta 2009;1792:482-96.
30. Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem 1999; 274:34893-902.
31. Fernandes ML, Saad MJ, Velloso LA. Effects of age on elements of insulin-signaling pathway in central nervous system of rats. Endocrine 2001;16:227-34.
32. Liu X, Zheng M, Hao Y, Hou L, Zhang S. Effects of Pioglitazone on cognition function and AGEs-RAGE system in insulin resistance in rats. J Shandong Univ (Health Sci) 2008;46:954-8.
33. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005;120:701-13.
34. Wu L, Zhu W, Pei Y, Qu Z, Tong J, Zhang T, et al. Correlational study between cognitive function and serum cytokine concentration in senile dementia patients. Chin J Clin 2012;6:135-8.
35. Hamed SA, Youssef AH, Elserogy YE, Herdan O, Abd-Elaal RF, Metwaly NA, et al. Cognitive function in patients with Type 2 Diabetes Mellitus: Relationship to stress hormone (Cortisol). J Neurol Neurosci 2013;4:3.
36. Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-38.